VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $27,341 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $27,341 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $73,953 | $50,180 | $43,035 | $15,980 |
| G&A Expenses | $33,912 | $35,807 | $14,019 | $8,233 |
| SG&A Expenses | $33,912 | $35,807 | $14,019 | $8,233 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $729 | $207 | $102 |
| Operating Expenses | $107,865 | $86,716 | $57,261 | $24,315 |
| Operating Income | -$80,524 | -$86,716 | -$57,261 | -$24,315 |
| % Margin | -294.5% | – | – | – |
| Other Income/Exp. Net | -$13,104 | -$293 | -$2,682 | $834 |
| Pre-Tax Income | -$93,628 | -$86,945 | -$59,943 | -$23,481 |
| Tax Expense | $107 | $64 | $554 | $50 |
| Net Income | -$93,735 | -$87,009 | -$60,497 | -$23,531 |
| % Margin | -342.8% | – | – | – |
| EPS | -2.12 | -3.23 | -2.4 | -1.01 |
| % Growth | 34.4% | -34.6% | -137.6% | – |
| EPS Diluted | -2.12 | -3.23 | -2.4 | -1.01 |
| Weighted Avg Shares Out | 44,127 | 26,957 | 25,155 | 23,353 |
| Weighted Avg Shares Out Dil | 44,127 | 26,957 | 25,155 | 23,353 |
| Supplemental Information | – | – | – | – |
| Interest Income | $676 | $0 | $1 | $15 |
| Interest Expense | $3,164 | $36 | $554 | $50 |
| Depreciation & Amortization | $676 | $303 | -$293 | $167 |
| EBITDA | -$79,848 | -$86,413 | -$57,554 | -$23,264 |
| % Margin | -292% | – | – | – |